-
effectivehealthcare-admin.ahrq.gov/products/fibromyalgia/research-protocol
April 03, 2014 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/radiation-therapy-bone-metastases/protocol
June 23, 2022 - studies that do not provide randomization, allocation, and/or blinding details, have a high rate of study loss-to-followup
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-quantitative-synthesis/methods
October 25, 2010 - numerous ways including population characteristics, interventions and cointerventions, length of followup, loss
-
digital.ahrq.gov/sites/default/files/docs/page/guide-to-evaluating-hie-projects-section-6.pdf
November 14, 2014 - This
resource is freely
available.
34
• Impact on lost
films
• Logs The post-
implementation loss
-
www.ahrq.gov/sites/default/files/2024-01/jones1-report.pdf
January 01, 2024 - Taping
difficulties led to the loss of nine interviews.
-
www.ahrq.gov/sites/default/files/2024-07/cebul-report.pdf
January 01, 2024 - Four risk factors for severe visual loss in
diabetic retinopathy: the third report of the Diabetic Retinopathy
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_3_communication.pptx
July 01, 2023 - To Check-Back
During handoffs and care transitions
In response to a call-out
Especially about blood loss
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
March 01, 2016 - Mediolateral
episiotomy is associated with difficulty of repair, greater blood loss, and possibly, increased
-
effectivehealthcare.ahrq.gov/health-topics/wildfires
-
effectivehealthcare.ahrq.gov/health-topics/floods
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - CDI prevalence.12
No new data from either
the FDA or MHRA
and B, with no or relatively
modest loss … substantially more
sensitive than many immunoassays for toxins A and B,
with no or relatively modest loss
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
July 01, 2014 - acute life threatening
event
Preferences for ongoing
management of chronic
illness in event of loss … A
patient may need to review data on life-expectancy and likelihood of pain or loss of function in
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
February 01, 2015 - effectiveness and safety for sleeve gastrectomy
suggested that it is less effective than RYGB for weight loss … but associated
with a reduced risk for complications, and more effective for weight loss
compared
-
hcup-us.ahrq.gov/db/nation/kid/KID_2006_Introduction.pdf
January 01, 2006 - arthritis/collagen
vascular diseases
CM_BLDLOSS 2003, 2006 AHRQ comorbidity measure: Chronic blood loss … AHRQ comorbidity measure: Valvular disease
CM_WGHTLOSS 2003, 2006 AHRQ comorbidity measure: Weight loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
February 01, 2015 - effectiveness and safety for sleeve gastrectomy
suggested that it is less effective than RYGB for weight loss … but associated
with a reduced risk for complications, and more effective for weight loss
compared
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2006.jsp
January 01, 2006 - arthritis/collagen vascular diseases
CM_BLDLOSS
2002-2006
AHRQ comorbidity measure: Chronic blood loss … comorbidity measure: Valvular disease
CM_WGHTLOSS
2002-2006
AHRQ comorbidity measure: Weight loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
July 01, 2014 - acute life threatening
event
Preferences for ongoing
management of chronic
illness in event of loss … A
patient may need to review data on life-expectancy and likelihood of pain or loss of function in
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - CDI prevalence.12
No new data from either
the FDA or MHRA
and B, with no or relatively
modest loss … substantially more
sensitive than many immunoassays for toxins A and B,
with no or relatively modest loss
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/draft-report-plant-based-treatment.pdf
March 01, 2021 - Nonserious adverse effects include hyperpigmentation of the skin, constipation, weight loss,
insomnia … , xerostomia, and loss of libido.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TJhx6cZFX9K7RoDQJNcM6
November 18, 2016 - Methodological limitations in the poor-quality studies
included high loss to follow-up or failure to … Loss to follow-up
was 14% (46/334) in the calcium group and 18% (59/336) in the pla-
cebo group.